News & Updates
最新消息
Our latest study in Journal of Biomedical Science reveals how CD24a knockout promotes M1 macrophage infiltration and cytotoxic CD8+ T cell recruitment in tumor environments.
本實驗室最新發表於 Journal of Biomedical Science 的研究揭示 CD24a 基因剔除如何促進腫瘤微環境中 M1 巨噬細胞浸潤及細胞毒性 CD8+ T 細胞的招募。
Collaborative study reveals how ST6GAL1-mediated sialylation of PECAM-1 promotes lung tropism of metastatic breast cancer, published in Cancer Research.
合作研究揭示 ST6GAL1 介導的 PECAM-1 唾液酸化如何促進轉移性乳癌的肺趨向性，成果發表於 Cancer Research。
Dr. Chan published a comprehensive review tracing CD24's journey from oncogenesis regulator to promising immunotherapeutic target in Frontiers in Immunology.
詹博士於 Frontiers in Immunology 發表 CD24 從腫瘤形成調節因子到免疫治療靶點的全面綜述。
Our work on dual antibody-aided mesoporous nanoreactors combining chemodynamic therapy and immune checkpoint blockade in TNBC was published.
雙抗體輔助介孔奈米反應器結合化學動力療法與免疫檢查點阻斷用於三陰性乳癌的研究正式發表。
New study published in Journal of Biomedical Science reveals SCEL's role in regulating TNF-α/NF-κB axis to control lung colonization in triple-negative breast cancer.
發表於 Journal of Biomedical Science 的新研究揭示 SCEL 在調控 TNF-α/NF-κB 軸以控制三陰性乳癌肺部定植中的作用。
Dr. Chan participated in academic lectures, teacher community activities, and received awards recognizing research excellence in January 2026.
詹博士於 2026 年 1 月參與學術演講、教師社群活動，並榮獲多項表彰研究卓越的獎項。